HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$4.00
Day range
$3.97 - $4.38
Year range
$2.62 - $7.77
Market cap
227.64M USD
Avg Volume
112.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.04M | 9.61% |
Net income | -17.72M | -59.52% |
Net profit margin | — | — |
Earnings per share | -0.31 | -55.00% |
EBITDA | -20.26M | -42.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 229.67M | -15.15% |
Total assets | 237.48M | -14.82% |
Total liabilities | 9.56M | 3.46% |
Total equity | 227.92M | — |
Shares outstanding | 56.77M | — |
Price to book | 1.00 | — |
Return on assets | -20.85% | — |
Return on capital | -21.52% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.72M | -59.52% |
Cash from operations | -16.79M | -34.97% |
Cash from investing | 7.87M | -61.83% |
Cash from financing | 23.00K | 15.00% |
Net change in cash | -8.90M | -208.53% |
Free cash flow | -10.79M | -22.19% |
About
Founded
2017
Headquarters
Website
Employees
56
